We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
+11.78%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
AUM
$9.79B
AUM Growth
-$1.62B
Cap. Flow
-$2.29B
Cap. Flow %
-23.44%
Top 10 Hldgs %
25.19%
Holding
2,139
New
733
Increased
336
Reduced
386
Closed
673

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$272M
2
META icon
Meta Platforms (Facebook)
META
+$79.7M
3
NVDA icon
NVIDIA
NVDA
+$74.6M
4
PG icon
Procter & Gamble
PG
+$60.5M
5
MSFT icon
Microsoft
MSFT
+$58.1M

Top Sells

Rank Stock Value
1
PARA
Paramount Global Class B
PARA
+$158M
2
PPL
PPL Corp
PPL
+$113M
3
SO icon
Southern Company
SO
+$111M
4
DHR icon
Danaher
DHR
+$106M
5
ETR icon
Entergy
ETR
+$84.5M

Sector Composition

Rank Sector Weight
1 Technology 14.92%
2 Industrials 9.39%
3 Financials 9.29%
4 Consumer Discretionary 7.56%
5 Utilities 6.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RES icon
1276
RPC Inc
RES
$1.36B
$340K ﹤0.01%
71,475
-113,244
-61% -$535K
VNDA icon
1277
Vanda Pharmaceuticals
VNDA
$321M
$340K ﹤0.01%
68,103
+46,561
+216% +$216K
CRCT icon
1278
Cricut
CRCT
$1.18B
$339K ﹤0.01%
+53,945
New +$316K
RDW icon
1279
Redwire
RDW
$2.91B
$336K ﹤0.01%
37,418
-587,300
-94% -$6.87M
SVM
1280
Silvercorp Metals
SVM
$2.77B
$334K ﹤0.01%
+52,869
New +$259K
TFPM icon
1281
Triple Flag Precious Metals
TFPM
$7.01B
$333K ﹤0.01%
11,394
-18,106
-61% -$468K
DEO icon
1282
Diageo
DEO
$53.5B
$331K ﹤0.01%
+3,469
New +$364K
CCEP icon
1283
Coca-Cola Europacific Partners
CCEP
$48.4B
$330K ﹤0.01%
+3,655
New +$339K
URGN icon
1284
UroGen Pharma
URGN
$2.29B
$330K ﹤0.01%
+16,543
New +$297K
TDC icon
1285
Teradata
TDC
$2.56B
$322K ﹤0.01%
+14,962
New +$322K
PLGO
1286
Pelagos Insurance Capital
PLGO
$2.06B
$320K ﹤0.01%
+17,638
New +$294K
AVA icon
1287
Avista
AVA
$3.16B
$319K ﹤0.01%
+8,432
New +$313K
ESLT icon
1288
Elbit Systems
ESLT
$34.5B
$319K ﹤0.01%
+625
New +$293K
GPRE icon
1289
Green Plains
GPRE
$1.05B
$317K ﹤0.01%
36,115
+8,313
+30% +$72.8K
NRGV icon
1290
Energy Vault
NRGV
$675M
$317K ﹤0.01%
106,764
+95,462
+845% +$157K
VSTM icon
1291
Verastem
VSTM
$627M
$317K ﹤0.01%
+35,900
New +$267K
CCSI icon
1292
Consensus Cloud Solutions
CCSI
$700M
$317K ﹤0.01%
10,779
-8,693
-45% -$215K
MRC
1293
DELISTED
MRC Global
MRC
$316K ﹤0.01%
21,938
-114,053
-84% -$1.62M
GIC icon
1294
Global Industrial
GIC
$1.53B
$316K ﹤0.01%
8,605
-5,494
-39% -$184K
LION icon
1295
Lionsgate Studios
LION
$3.48B
$315K ﹤0.01%
+45,632
New +$294K
VREX icon
1296
Varex Imaging
VREX
$781M
$313K ﹤0.01%
25,261
-13,862
-35% -$137K
VRDN icon
1297
Viridian Therapeutics
VRDN
$2.74B
$311K ﹤0.01%
+14,413
New +$260K
CLBT icon
1298
Cellebrite
CLBT
$2.82B
$309K ﹤0.01%
+16,663
New +$262K
FRPH icon
1299
FRP Holdings
FRPH
$436M
$308K ﹤0.01%
+12,650
New +$329K
CGAU
1300
Centerra Gold
CGAU
$4.55B
$307K ﹤0.01%
28,600
-11,180
-28% -$89.2K

Similar funds

Michael Gelband's Q3 2025 Portfolio in Review

As of Q3 2025, Michael Gelband held 2,139 positions worth $9.79B, down 14% from $11.4B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Michael Gelband withdrew a net $2.29B in Q3 2025, closing 673 positions and reducing 386 holdings. Its most notable exit was Paramount Global Class B, an estimated $158M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 7.6% a quarter earlier, followed by Industrials and Financials.

Against the trend, Michael Gelband opened a new position in Apple worth $306M.

  • Michael Gelband's largest Q3 2025 buy was Apple: 1,202,327 shares worth $306M.
  • Michael Gelband added most to Procter & Gamble in Q3 2025, an estimated $60.5M increase.
  • Michael Gelband's biggest Q3 2025 reduction was PPL Corp, cutting an estimated $113M.
  • Michael Gelband fully exited Paramount Global Class B in Q3 2025, selling an estimated $158M.
  • Michael Gelband's ten largest holdings make up 25% of its $9.79B portfolio in Q3 2025.
  • Michael Gelband opened 733 new positions and closed 673 in Q3 2025.
  • Michael Gelband's portfolio value fell 14% quarter-over-quarter to $9.79B.

Based on ExodusPoint Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.